Differential effects of ciproxifan and nicotine on impulsivity and attention measures in the 5-choice serial reaction time test

This publication has 58 references indexed in Scilit:

• Evidence for tolerance following repeated dosing in rats with ciproxifan, but not with A-304121
  Life Sciences, 2006
• A Summary of the FDA-NIMH-MATRICS Workshop on Clinical Trial Design for Neurocognitive Drugs for Schizophrenia
  Schizophrenia Bulletin, 2005
• Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS
  Published by Elsevier ,2004
• Perspectives on cognitive domains, H₃receptor ligands and neurological disease
  Expert Opinion on Investigational Drugs, 2004
• Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder
  Pediatric Drugs, 2003
• Application of genomics to drug design: the example of the histamine H3 receptor
  European Neuropsychopharmacology, 2001
• Cognitive implications for H3 and 5-HT3 receptor modulation of cortical cholinergic function: A parallel story
  Methods and Findings in Experimental and Clinical Pharmacology, 1998
• Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice
  Life Sciences, 1995
• Clinical Studies with Oxiracetam in Patients with Dementia of Alzheimer Type and Multi-lnfarct Dementia of Mild to Moderate Degree
  Neuropsychobiology, 1992
• Effects of chronic nicotine administration and age in male Fischer-344 rats
  Toxicology and Applied Pharmacology, 1973